IGF-1 LR3

Research

IGF-1 LR3 (Long Arg3-IGF-1)

Category
Growth Hormone
Aliases
Long R3 IGF-1, Long-Arg3-IGF-1
Administration
Subcutaneous injection

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Hypoglycemia risk

Because this compound has insulin-like activity, blood sugar can drop too low, particularly if not paired with adequate food intake.

Potential for uncontrolled tissue growth with misuse

Because of its potent growth-signaling activity, excessive or prolonged use carries a theoretical risk of abnormal tissue growth.

Injection site reactions

Mild redness, swelling, or discomfort at the site of injection.